Industry News
Pharmaceutical Industry News
With $68.2M investment from India’s Serum, Oxford Biomedica set to add capacity and 120 jobs at its ‘Oxbox’ site
With $68.2M investment from India's Serum, Oxford Biomedica set to add capacity and 120 jobs at its 'Oxbox' site jkeenan Wed, 09/22/2021 - 11:06
Novartis reshuffling doesn’t portend a pullback from gene therapy, company says
Novartis reshuffling doesn't portend a pullback from gene therapy, company says kdunleavy Wed, 09/22/2021 - 10:42
Struggling with Alzheimer’s launch, Biogen couldn’t present ‘clear case for growth’ outside of Aduhelm: analyst
Struggling with Alzheimer's launch, Biogen couldn't present 'clear case for growth' outside of Aduhelm: analyst nhigginsdunn Wed, 09/22/2021 - 10:08
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world
Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world esagonowsky Wed, 09/22/2021 - 10:01
Incyte’s Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear
Incyte's Jakafi sister med clears FDA for atopic dermatitis, but safety warning a heavy cross to bear aliu Wed, 09/22/2021 - 07:42
It’s All or Nothing for These Democrats, Even if That Means Biden Fails
The moderates’ immodest demands threaten the president’s agenda.
Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels.
AstraZeneca lays out $360M for ‘next-gen’ manufacturing plant in Dublin
AstraZeneca lays out $360M for 'next-gen' manufacturing plant in Dublin esagonowsky Tue, 09/21/2021 - 11:28
Verrica’s lead drug VP-102 rejected by FDA thanks to issues at contract manufacturer
Verrica's lead drug VP-102 rejected by FDA thanks to issues at contract manufacturer jkeenan Tue, 09/21/2021 - 10:26
Seagen, Genmab gun for Merck’s Keytruda in cervical cancer with accelerated FDA nod for ADC therapy Tivdak
Seagen, Genmab gun for Merck's Keytruda in cervical cancer with accelerated FDA nod for ADC therapy Tivdak nhigginsdunn Tue, 09/21/2021 - 10:07
Johnson & Johnson trots out two-dose COVID vaccine data as it builds case for boosters
Johnson & Johnson trots out two-dose COVID vaccine data as it builds case for boosters kdunleavy Tue, 09/21/2021 - 09:52
Merck women’s health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy
Merck women's health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy nmissakian Tue, 09/21/2021 - 09:32
Virpax raises $40M to use delivery systems to improve pain drugs
Virpax raises $40M to use delivery systems to improve pain drugs ntaylor Tue, 09/21/2021 - 09:29
Scancell taps PharmaJet for needle-free COVID-19 vaccine study
Scancell taps PharmaJet for needle-free COVID-19 vaccine study ntaylor Tue, 09/21/2021 - 09:23
AGC Biologics on an expansion roll with more capacity planned at German plant
AGC Biologics on an expansion roll with more capacity planned at German plant jkeenan Tue, 09/21/2021 - 09:08
Investor snaps up drug delivery specialist Acino in bid to build regional pharma hub
Investor snaps up drug delivery specialist Acino in bid to build regional pharma hub ntaylor Tue, 09/21/2021 - 08:53
MHRA flags risk of topical steroid withdrawal reactions
MHRA flags risk of topical steroid withdrawal reactions ntaylor Tue, 09/21/2021 - 08:47
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028 esagonowsky Tue, 09/21/2021 - 08:43
Why Covid Vaccines for Kids Are Taking the F.D.A. So Long
The F.D.A. needs a new system for responding to pandemics.
What Is 23andMe Doing With Your DNA?
C.E.O. Anne Wojcicki grapples with the ethical questions that come with building a business on customers’ personal information.